Palvella Therapeutics (@palvellatx) 's Twitter Profile
Palvella Therapeutics

@palvellatx

Palvella Therapeutics ($PVLA) is #biotech focused on novel therapies for patients with serious, rare genetic skin diseases w/ no FDA approved therapies.

ID: 955707785634775040

linkhttps://www.palvellatx.com calendar_today23-01-2018 07:44:27

111 Tweet

578 Followers

106 Following

Palvella Therapeutics (@palvellatx) 's Twitter Profile Photo
Palvella Therapeutics
@palvellatx

3 years ago

We are excited to announce the dosing of the first subject in the phase 1 healthy volunteer study of PRS-220, an inhaled CTGF inhibitor we are developing for #IPF!

We are excited to announce the dosing of the first subject in the phase 1 healthy volunteer study of PRS-220, an inhaled CTGF inhibitor we are developing for #IPF!